We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
401
DELISTED
Brookline Bancorp
BRKL
| $583K | 0.09% |
43,803
+20,046
| +84% | +$288K |
|
|
CHX
402
DELISTED
ChampionX
CHX
| $583K | 0.09% |
+29,359
| New | +$663K |
|
|
VRAY
403
DELISTED
ViewRay, Inc.
VRAY
| $583K | 0.09% |
219,957
-126,704
| -37% | -$381K |
|
|
RFP
404
DELISTED
Resolute Forest Products Inc.
RFP
| $583K | 0.09% |
+45,659
| New | +$631K |
|
405
Carriage Services
CSV
$573M
| $582K | 0.09% |
14,670
-7,683
| -34% | -$332K |
|
406
AZZ Inc
AZZ
$4.54B
| $581K | 0.09% |
14,229
+655
| +5% | +$29.4K |
|
|
CLDT
407
Chatham Lodging
CLDT
$589M
| $581K | 0.09% |
+55,557
| New | +$699K |
|
408
Ginkgo Bioworks
DNA
$516M
| $580K | 0.09% |
+6,096
| New | +$744K |
|
|
HAYN
409
DELISTED
Haynes International, Inc.
HAYN
| $580K | 0.09% |
17,712
+1,388
| +9% | +$53.8K |
|
|
FYBR
410
DELISTED
Frontier Communications
FYBR
| $579K | 0.09% |
+24,577
| New | +$629K |
|
411
Doximity
DOCS
$5.21B
| $577K | 0.09% |
+16,557
| New | +$652K |
|
412
Vertex
VERX
$1.93B
| $577K | 0.09% |
50,967
+24,046
| +89% | +$304K |
|
|
SLCA
413
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $577K | 0.09% |
+50,515
| New | +$848K |
|
414
Plexus
PLXS
$7.24B
| $576K | 0.09% |
+7,335
| New | +$595K |
|
415
Materion
MTRN
$6.04B
| $575K | 0.09% |
7,793
-4,141
| -35% | -$333K |
|
416
First Advantage
FA
$4.21B
| $571K | 0.09% |
45,106
+34,818
| +338% | +$550K |
|
417
Reliance Steel & Aluminium
RS
$21.6B
| $571K | 0.09% |
3,364
-518
| -13% | -$96.7K |
|
418
Kyndryl
KD
$3.04B
| $570K | 0.09% |
+58,260
| New | +$678K |
|
419
UNIFI
UFI
$136M
| $570K | 0.09% |
40,542
-23,486
| -37% | -$354K |
|
420
Arcos Dorados Holdings
ARCO
$1.73B
| $569K | 0.09% |
84,480
+57,497
| +213% | +$425K |
|
421
Diamondback Energy
FANG
$52.4B
| $567K | 0.09% |
4,682
-1,079
| -19% | -$148K |
|
422
Artivion
AORT
$1.33B
| $566K | 0.08% |
29,985
-74,163
| -71% | -$1.43M |
|
423
Graham Holdings Company
GHC
$5.03B
| $565K | 0.08% |
997
-1,154
| -54% | -$687K |
|
424
Bilibili
BILI
$7.81B
| $563K | 0.08% |
22,008
-406
| -2% | -$9.77K |
|
425
Carrier Global
CARR
$52.7B
| $563K | 0.08% |
15,782
+10,644
| +207% | +$418K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.